Featured Research

from universities, journals, and other organizations

A Single Subjective Question Can Be An Effective Sleepiness Screening Tool

Date:
April 15, 2008
Source:
American Academy of Sleep Medicine
Summary:
A single subjective question may be an effective screening tool for excessive daytime sleepiness. The question is: "Please measure your sleepiness on a typical day: (0 = none, 10 is highest)."

A single subjective (SS) question may be an effective screening tool for excessive daytime sleepiness, according to a study published in the April 15 issue of the Journal of Clinical Sleep Medicine (JCSM).

Sarah Nath Zallek, MD, of the Illinois Neurological Institute Sleep Center in Peoria, Ill., sought to determine whether the following single question about sleepiness can measure subjective sleepiness comparably to the Epworth Sleepiness Scale (ESS):

"Please measure your sleepiness on a typical day: (0 = none, 10 is highest)."

The study focused on 303 subjects between 18-78 years of age, who had been diagnosed with a variety of sleep disorders, including obstructive or central sleep apnea, narcolepsy, periodic limb movement disorder, restless legs syndrome, psychophysiological insomnia, inadequate sleep hygiene, and idiopathic hypersomnia. ESS scores ranged from 0-24, while SS scores ranged from 0-10.

According to Dr. Zallek, the finding that the single question used in this study had significant associations with the ESS in all subject groups and was able to distinguish between "subjectively sleepy" and "subjectively not sleepy" groups suggests the SS is a good measure of subjective sleepiness.

"Excessive sleepiness is an important and widespread symptom of insufficient sleep and a variety of sleep disorders," said Dr. Zallek. "It increases the risk of accidents and injuries, and leads to lost work productivity. Recognition of sleepiness is the first step to finding a cause and treating it. Most physicians don't use the existing questionnaires to determine if someone is excessively sleepy. Sleepiness often goes unrecognized."

By using a single question to detect excessive sleepiness, one can quickly determine who might need further evaluation, noted Dr. Zallek.

"This scale can also assess change in an individual's sleepiness over time. This study provides individuals, physicians, and employers a simple, single question to initiate an evaluation of this important symptom," added Dr. Zallek.

On average, most adults need seven to eight hours of nightly sleep to feel alert and well-rested.


Story Source:

The above story is based on materials provided by American Academy of Sleep Medicine. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Sleep Medicine. "A Single Subjective Question Can Be An Effective Sleepiness Screening Tool." ScienceDaily. ScienceDaily, 15 April 2008. <www.sciencedaily.com/releases/2008/04/080415101042.htm>.
American Academy of Sleep Medicine. (2008, April 15). A Single Subjective Question Can Be An Effective Sleepiness Screening Tool. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/04/080415101042.htm
American Academy of Sleep Medicine. "A Single Subjective Question Can Be An Effective Sleepiness Screening Tool." ScienceDaily. www.sciencedaily.com/releases/2008/04/080415101042.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins